of 35
8/9/2019 ENZYMOLOGY (3)
1/35
MORE ON ENZYMESMORE ON ENZYMES
JULIUS P. MARIO, RMT, MSJULIUS P. MARIO, RMT, MS
8/9/2019 ENZYMOLOGY (3)
2/35
ENZYME REGULATIONENZYME REGULATION
Feedback ControlFeedback Control
ProenzymesProenzymes
AllosterismAllosterism
Protein ModificationProtein Modification
IsoenzymesIsoenzymes
8/9/2019 ENZYMOLOGY (3)
3/35
FEEDBACK CONTROLFEEDBACK CONTROL
Formation of the product inhibits anFormation of the product inhibits anearlier reaction in a sequenceearlier reaction in a sequence
In the reaction,In the reaction, E1 E2 E3E1 E2 E3
AA BB CC DD
D may inhibit E1 activity by competitive orD may inhibit E1 activity by competitive ornoncompetitive inhibitionnoncompetitive inhibition
When D is low, all three reactions proceed rapidlyWhen D is low, all three reactions proceed rapidly
When D is high, E1 becomes inhibitedWhen D is high, E1 becomes inhibited
8/9/2019 ENZYMOLOGY (3)
4/35
PROENZYMESPROENZYMES Inactive form of an enzymeInactive form of an enzyme
Also known as zymogenAlso known as zymogenActivated by cleavage of excess polypeptideActivated by cleavage of excess polypeptide
chainchain
Cleavage of peptide promotes structuralCleavage of peptide promotes structuralchanges, thus, functionalchanges, thus, functional
Examples areExamples are TrypsinogenTrypsinogen = cleavage of the 6 amino acids= cleavage of the 6 amino acids
from the Nfrom the N--terminal by enteropeptidase converts itterminal by enteropeptidase converts itto activeto active trypsintrypsin
AngiotensinogenAngiotensinogen = cleavage of the last 2 amino= cleavage of the last 2 aminoacids from the Cacids from the C--terminal byterminal byACEACE converts it to aconverts it to a
vasoactive octapeptide,vasoactive octapeptide, angiotensinangiotensin
8/9/2019 ENZYMOLOGY (3)
5/35
PROENZYMESPROENZYMES
ChymotrypsinogenChymotrypsinogen = cleavage of the 245= cleavage of the 245residues long polypeptide between Rresidues long polypeptide between R--15 and15 andII--16 from the N16 from the N--terminal by trypsin converts itterminal by trypsin converts itto activeto active --chymotrypsin but the fully activechymotrypsin but the fully active
form isform is --chymotrypsinchymotrypsin
8/9/2019 ENZYMOLOGY (3)
6/35
PROENZYMESPROENZYMES
Some enzymes have proenzymes becauseSome enzymes have proenzymes becausethey are highly destructive when producedthey are highly destructive when produced
directly in their active formsdirectly in their active forms
Should these leak or exist in excess,Should these leak or exist in excess,inhibitory proteins bind them to renderinhibitory proteins bind them to renderthem inactivethem inactive
8/9/2019 ENZYMOLOGY (3)
7/35
ALLOSTERISMALLOSTERISM
If a substance binds noncovalently andIf a substance binds noncovalently andreversibly to a sitereversibly to a site other than the activeother than the active
site,site, It may inhibit the enzymeIt may inhibit the enzyme
(Negative modulation)(Negative modulation)
Itmay stimulate enzyme actionItmaystimulate enzyme action
(Positive modulation)(Positive modulation)
8/9/2019 ENZYMOLOGY (3)
8/35
ALLOSTERISMALLOSTERISM
AlloAllomeans other;means other; stericstericmeans shapemeans shape
Possible conformationalchanges affect thePossible conformationalchanges affect thebehavior of proteinsbehavior of proteins
Due tomultiple forms of theDue tomultiple forms of the quaternaryquaternarystructurestructure of some allosteric enzymesof some allosteric enzymes
A substance that modifies 4A substance that modifies 4o structure andstructure and
thus, affect behavior is anthus, affect behavior is an allosteric effectorallosteric effector AllostericeffectorsAllostericeffectors are substrates,are substrates,
activators, and inhibitorsactivators, and inhibitors
8/9/2019 ENZYMOLOGY (3)
9/35
ALLOSTERIC PROTEINSALLOSTERIC PROTEINS Proteins in which subtle changes at one siteProteins in which subtle changes at one site
affects theaffects the structure and functionstructure and function ofofanother siteanother site
Due toDue to cooperativecooperative effectseffects
Depicted asDepicted as sigmoidal curvesigmoidal curve on enzymeon enzyme
kineticskinetics
Examples areExamples are Aspartate transcarbamoylaseAspartate transcarbamoylase(ATCase) &(ATCase) & HemoglobinHemoglobin
8/9/2019 ENZYMOLOGY (3)
10/35
NONALLOSTERIC PROTEINSNONALLOSTERIC PROTEINS
At first, dependent on the [S] with aAt first, dependent on the [S] with amaximal rate not dependent on [S]maximal rate not dependent on [S]
anymoreanymore
Depicted as aDepicted as a hyperbolichyperbolic curve oncurve onMichaelisMichaelis--Menten kineticsMenten kinetics
Examples areExamples are chymotrypsinchymotrypsin && myoglobinmyoglobin
8/9/2019 ENZYMOLOGY (3)
11/35
HOMOTROPIC vs. HETEROTROPICHOMOTROPIC vs. HETEROTROPIC
EffectsEffects HomotropicHomotropic effectseffects areare allostericallosteric
interactionsinteractions thatthat occuroccur whenwhen severalseveralidenticalidentical moleculesmolecules areare boundbound toto aaproteinprotein..
HeterotropicHeterotropic effectseffects areare allostericallostericinteractionsinteractions thatthat occuroccur whenwhen differentdifferentsubstancessubstancesareare boundbound toto aa proteinprotein..
8/9/2019 ENZYMOLOGY (3)
12/35
PROTEIN MODIFICATIONPROTEIN MODIFICATION Modification is usually a change in theModification is usually a change in the
primary structure,primary structure, typically by the additiontypically by the additionof a functional group covalently bound toof a functional group covalently bound tothe apoenzymethe apoenzyme
BestBest--known example is theknown example is theactivation/inhibition ofphosphorylationactivation/inhibition ofphosphorylation Glycogen phosphorylaseGlycogen phosphorylase is active when it isis active when it is
phosphorylated at its serine or tyrosinephosphorylated at its serine or tyrosineresidueresidue
Pyruvate kinasePyruvate kinase from the liver is inactivefrom the liver is inactive
when it is phosphorylatedwhen it is phosphorylated
8/9/2019 ENZYMOLOGY (3)
13/35
ISOENZYMESISOENZYMES Enzymes that perform the same functionEnzymes that perform the same function
but have different combinations ofbut have different combinations ofsubunits, thus have different 4subunits, thus have different 4o structuresstructures
Have different electrophoretic mobilities,Have different electrophoretic mobilities,Km, and originsKm, and origins
Act on the same substrateAct on the same substrate
LDH has 4 subunitsLDH has 4 subunits LD1 (LD1 (HH44), LD2 (), LD2 (HH33MM), LD3 (), LD3 (HH22MM22), LD4), LD4
((H
MH
M33) & LD5 () & LD5 (MM44))
8/9/2019 ENZYMOLOGY (3)
14/35
CARBOXYPEPTIDASESCARBOXYPEPTIDASES
CleaveCleave peptidespeptides andand proteinsproteins atat thethe carboxylcarboxylterminalterminal ofof aa particularparticular aminoamino acidacid inin thethechainchain
TrypsinTrypsin == atatlysyllysyloror arginylarginyl
ChymotrypsinChymotrypsin == atatphenylalanylphenylalanyl,,
tryptophanyltryptophanyl oror tyrosyltyrosylasaswellwellasas L,L, HH && QQ
PepsinPepsin == samesame withwith chymotrypsinchymotrypsin andand othersothers
ThermolysinThermolysin == atatisoleucylisoleucyl,, leucylleucyl oror valylvalyl
8/9/2019 ENZYMOLOGY (3)
15/35
PROTEASE FAMILYPROTEASE FAMILY
All members have similar chemical formAll members have similar chemical form
Serine ProteasesSerine Proteases = cleaves at seryl residues= cleaves at seryl residues((chymotrypsinchymotrypsin,, trypsintrypsinandand elastinelastin))
Cysteine proteaseCysteine protease = cleaves at cysteinyl= cleaves at cysteinylresidue (residue (papainpapain, a meat tenderizer), a meat tenderizer)
Aspartyl proteaseAspartyl protease = a pair of aspartate side= a pair of aspartate sidechains, sometimes on different subunitschains, sometimes on different subunitsparticipate in the reaction (participate in the reaction (pepsinpepsin andand HIVHIVproteaseprotease))
8/9/2019 ENZYMOLOGY (3)
16/35
ABZYMESABZYMESAntibodies elicited by antigenic proteinsAntibodies elicited by antigenic proteins
Designer enzymes which can catalyze aDesigner enzymes which can catalyze awide variety of reactionswide variety of reactions
Usually areUsually are transitiontransition--state analogsstate analogs whichwhichwhen introduced into the body becomeswhen introduced into the body becomesimmunogenicimmunogenic
NN--(5(5--phosphopyridoxyl)phosphopyridoxyl)--LL--lysinelysine isisthe transitionthe transition--state analog for the reactionstate analog for the reactionbetween an amino acid and pyridoxalbetween an amino acid and pyridoxal--55--phosphatephosphate
8/9/2019 ENZYMOLOGY (3)
17/35
CELLULAR LEVELCELLULAR LEVEL SER enzymesSER enzymes
Detoxification by theDetoxification by the cytochrome Pcytochrome P--450450enzymesenzymes
Lipid synthesis & degradation byLipid synthesis & degradation byCytosolic sideCytosolic side = cyt b5, cyt b5reductase,= cyt b5, cyt b5reductase,NADPHNADPH--ferrihemoproteinreductase,ATPase,5ferrihemoproteinreductase,ATPase,5--NT, glycolipid mannosyl transferases,NT, glycolipid mannosyl transferases,hydroxymethylglutarylhydroxymethylglutaryl--CoAreductase, some 30CoAreductase, some 30
enzymes forsteroid synthesis and 20 enzymesenzymes forsteroid synthesis and 20 enzymesoflipid synthesisoflipid synthesis
Luminal sideLuminal side = cyt P= cyt P--450, cyt P450, cyt P--450reductase,450reductase,glucoseglucose--66--phosphatase andphosphatase and --glucuronidaseglucuronidase
8/9/2019 ENZYMOLOGY (3)
18/35
RERRER Transport enzymes for glycosylation of newlyTransport enzymes for glycosylation of newly
formed proteins;formed proteins; flippasesflippases for phospholipidfor phospholipidsynthesissynthesis
GOLGI BODYGOLGI BODY Enzymes for posttranslational modifications ofEnzymes for posttranslational modifications of
proteins synthesized on membranes as well asproteins synthesized on membranes as well asrecycling of membrane material;recycling of membrane material; 55--NT,NT,NADH:cytcoxidoreductase,NADPH:cytcNADH:cytcoxidoreductase,NADPH:cytcreductase, UDPreductase, UDP--galactosegalactose--NN--acetylglucosamineacetylglucosamine----DD--galactosyltransferase,galactosyltransferase,andand manymanyglycosylationenzymesglycosylationenzymes
8/9/2019 ENZYMOLOGY (3)
19/35
LYSOSOMESLYSOSOMES
Hydrolytic enzymes such asHydrolytic enzymes such as proteinases,proteinases,glycosidases,lipases,phosphatases,glycosidases,lipases,phosphatases,nucleases,nucleases,andand sulfatasessulfatases
MICROBODIESMICROBODIES
MainlyMainly oxidative enzymesoxidative enzymes
VACUOLESVACUOLES
VV--type Htype H++--translocatingATPasetranslocatingATPase
8/9/2019 ENZYMOLOGY (3)
20/35
BRUSH BORDER ENZYMESBRUSH BORDER ENZYMES
Disaccharidases found on the microvilli ofDisaccharidases found on the microvilli ofthe small intestinethe small intestine
Once lost, can be reOnce lost, can be re--synthesized viasynthesized viaenzyme inductionenzyme induction
Substrates commonly acted upon areSubstrates commonly acted upon aremaltose, sucrose, and lactosemaltose, sucrose, and lactose
8/9/2019 ENZYMOLOGY (3)
21/35
ENZYMES AS VIRULENCEENZYMES AS VIRULENCEFACTORSFACTORS
HelicobacterpyloriHelicobacterpylorisurvives the harshsurvives the harshgastricmilieu bythegastricmilieu bythe ureaseurease on its cellon its cellwall. The ammoniaproduced counters thewall. The ammoniaproduced counters theharmfuleffects ofthe acid.harmfuleffects ofthe acid.
Some pathogenic cocci are capable ofSome pathogenic cocci are capable ofproducingproducing hemolysinshemolysins which interferewhich interferewith oxygen transport in an organismwith oxygen transport in an organism
8/9/2019 ENZYMOLOGY (3)
22/35
EFFECTS ON ENZYMESEFFECTS ON ENZYMES Bactericidal antibiotics for both GramBactericidal antibiotics for both Gram
positive and Gram negative organisms actpositive and Gram negative organisms actvia inhibition of cell wall synthesizingvia inhibition of cell wall synthesizing
proteinsynthaseproteinsynthase (e.g. Carbapenems)(e.g. Carbapenems)
Binds to theBinds to the subunit ofsubunit ofRNARNA
polymerasepolymerase to inhibit transcription ofto inhibit transcription ofmostly Gram+ bacteria & Mycobacteriamostly Gram+ bacteria & Mycobacteria(e.g. Rifampin)(e.g. Rifampin)
8/9/2019 ENZYMOLOGY (3)
23/35
An example of a medicinal enzyme inhibitor isAn example of a medicinal enzyme inhibitor issildenafil (Viagra), a common treatment for malesildenafil (Viagra), a common treatment for male
erectile dysfunction.erectile dysfunction.
This compound is a potent inhibitor of cGMPThis compound is a potent inhibitor of cGMPspecific phosphodiesterase type 5, the enzymespecific phosphodiesterase type 5, the enzymethat degrades thethat degrades the signallingsignalling moleculemolecule cycliccyclic
guanosine monophosphateguanosine monophosphate..
This signalling molecule triggers smooth muscleThis signalling molecule triggers smooth musclerelaxation and allows blood flow into therelaxation and allows blood flow into the corpuscorpus
cavernosumcavernosum, which causes an erection. Since, which causes an erection. Sincethe drug decreases the activity of the enzymethe drug decreases the activity of the enzymethat halts the signal, it makes this signal last forthat halts the signal, it makes this signal last fora longer period of time.a longer period of time.
8/9/2019 ENZYMOLOGY (3)
24/35
Another example of the structural similarity ofAnother example of the structural similarity ofsome inhibitors to the substrates of the enzymessome inhibitors to the substrates of the enzymes
they target is seen in the figure comparing thethey target is seen in the figure comparing thedrugdrug methotrexatemethotrexate toto folic acidfolic acid. Folic acid is the. Folic acid is theoxidised form of the substrate ofoxidised form of the substrate ofdihydrofolatedihydrofolatereductasereductase, an enzyme that is potently inhibited, an enzyme that is potently inhibited
by methotrexate. Methotrexate blocks the actionby methotrexate. Methotrexate blocks the actionof dihydrofolate reductase and thereby haltsof dihydrofolate reductase and thereby haltsthymidinethymidine biosynthesis. This block ofbiosynthesis. This block ofnucleotidenucleotidebiosynthesis is selectively toxic to rapidlybiosynthesis is selectively toxic to rapidly
growing cells, therefore methotrexate is oftengrowing cells, therefore methotrexate is oftenused in cancerused in cancer chemotherapychemotherapy..
8/9/2019 ENZYMOLOGY (3)
25/35
Drugs also are used to inhibit enzymesDrugs also are used to inhibit enzymes
needed for the survival ofneeded for the survival ofpathogenspathogens. For. Forexample, bacteria are surrounded by aexample, bacteria are surrounded by athickthick cell wallcell wall made of a netmade of a net--like polymerlike polymercalledcalled peptidoglycanpeptidoglycan. Many antibiotics. Many antibiotics
such assuch as penicillinpenicillin andand vancomycinvancomycin inhibitinhibitthe enzymes (thethe enzymes (the transpeptidasetranspeptidase from thefrom thebacteriabacteria StreptomycesStreptomyces R61) that produceR61) that produce
and then crossand then cross--link the strands of thislink the strands of thispolymer together. This causes the cell wallpolymer together. This causes the cell wallto lose strength and the bacteria to burst.to lose strength and the bacteria to burst.
8/9/2019 ENZYMOLOGY (3)
26/35
Drug designDrug design is facilitated when an enzymeis facilitated when an enzymethat is essential to the pathogen's survivalthat is essential to the pathogen's survivalis absent or very different in humans.is absent or very different in humans.
Humans do not make peptidoglycan,Humans do not make peptidoglycan,
therefore inhibitors of this process aretherefore inhibitors of this process areselectively toxic to bacteria.selectively toxic to bacteria.
Selective toxicity is also produced inSelective toxicity is also produced inantibiotics by exploiting differences in theantibiotics by exploiting differences in thestructure of thestructure of the ribosomesribosomes in bacteria, orin bacteria, orhow they makehow they make fatty acidsfatty acids
8/9/2019 ENZYMOLOGY (3)
27/35
AcCHE, an enzyme found in animals from insects toAcCHE, an enzyme found in animals from insects tohumans. It is essential to nerve cell function through itshumans. It is essential to nerve cell function through itsmechanism of breaking down the neurotransmittermechanism of breaking down the neurotransmitter
acetylcholineacetylcholine into its constituents,into its constituents, acetateacetate andand cholinecholine..
This is somewhat unique among neurotransmitters asThis is somewhat unique among neurotransmitters asmost, includingmost, including serotoninserotonin,, dopaminedopamine, and, andnorepinephrinenorepinephrine, are absorbed from the, are absorbed from the synaptic cleftsynaptic cleft
rather than cleaved.rather than cleaved.
Reversible competitive inhibitorsReversible competitive inhibitors, such as, such asedrophoniumedrophonium,, physostigminephysostigmine, and, and neostigmineneostigmine, are used, are usedin the treatment ofin the treatment ofmyasthenia gravismyasthenia gravis and inand inanaesthesia. Theanaesthesia. The carbamatecarbamate pesticides are alsopesticides are alsoexamples of reversible AChE inhibitors.examples of reversible AChE inhibitors.
TheThe organophosphateorganophosphate insecticides such asinsecticides such as malathionmalathion,,parathionparathion, and, and chlorpyrifoschlorpyrifos irreversibly inhibitirreversibly inhibitacetylcholinesterase.acetylcholinesterase.
8/9/2019 ENZYMOLOGY (3)
28/35
ENZYME DEFICIENCIESENZYME DEFICIENCIES
8/9/2019 ENZYMOLOGY (3)
29/35
MUCOPOLYSACCHARIDOSISMUCOPOLYSACCHARIDOSISMPS Type Eponym Deficient EnzymeMPS Type Eponym Deficient Enzyme
I H Hurler aI H Hurler a--iduronidaseiduronidase
I H/S HurlerI H/S Hurler--Scheie aScheie a--iduronidaseiduronidase
I S Scheie aI S Scheie a--iduronidaseiduronidase
II Hunter Iduronidase sulfataseII Hunter Iduronidase sulfatase
III Sanfilippo A Heparan sulfataseIII Sanfilippo A Heparan sulfatase
Sanfilippo BSanfilippo B NN--acetylglucosaminidaseacetylglucosaminidase
Sanfilippo C Acetyl CoA glucosamineSanfilippo C Acetyl CoA glucosamineacetyltransferaseacetyltransferase
Sanfilippo DSanfilippo D NN--acetylglucosamineacetylglucosamine--66--sulfatasesulfatase
IV Morquio A GalactosamineIV Morquio A Galactosamine--66--sulfatasesulfatase
Morquio BMorquio B bb--galactosidasegalactosidaseV NonexistentV Nonexistent
VI Maroteaux VI Maroteaux--LamyLamy NN--acetylhexosamineacetylhexosamine--44--sulfatasesulfatase
VII Sly VII Sly bb--glucuronidaseglucuronidase
IX Hyaluronidase HyaluronidaseIX Hyaluronidase Hyaluronidase
DeficiencyDeficiency
8/9/2019 ENZYMOLOGY (3)
30/35
GLYCOGEN STORAGE DISEASESGLYCOGEN STORAGE DISEASES
TypeType -- Enzyme DeficientEnzyme Deficient --Clinical FeaturesClinical FeaturesII ((von Gierkevon Gierke)) -- Liver and kidneyLiver and kidney GlucoseGlucose--66--phosphatasephosphatase
Hepatomegaly, lactic acidosis, hyperlipidemia, severe fastingHepatomegaly, lactic acidosis, hyperlipidemia, severe fastinghypoglycemiahypoglycemia
II (Pompe)II (Pompe)--All tissuesAll tissuesalpha 1,4alpha 1,4--glucosidaseglucosidaseCardiomegaly, muscle weakness, death in infancy and adultsCardiomegaly, muscle weakness, death in infancy and adults
III (CoriIII (Cori--Forbes)Forbes)--All tissuesAll tissuesdebrancher enzymedebrancher enzymeHepatomgaly, muscle weakness, fasting hypoglycermiaHepatomgaly, muscle weakness, fasting hypoglycermia
IV (Andersen)IV (Andersen)-- All tissuesAll tissuesbrancher enzymebrancher enzyme
Portal cirrhosis, death in infancyPortal cirrhosis, death in infancy
V (McArdle)V (McArdle)-- Muscle phosphorylaseMuscle phosphorylase
Pain and stiffness after exertion; myoglobinuriaPain and stiffness after exertion; myoglobinuria
8/9/2019 ENZYMOLOGY (3)
31/35
VI (Hers)VI (Hers) Liver phosphorylaseLiver phosphorylase Hepatomegaly,Hepatomegaly,mild fastingmild fasting
hypoglycemiahypoglycemia
VII (Tarui)VII (Tarui) Muscle and liverMuscle and liverphosphofructokinasephosphofructokinase
Pain and stiffnessPain and stiffnesson exertionon exertion
VIIIVIII Brain and liverBrain and liveradenylate kinaseadenylate kinase
Spasticity,Spasticity,decerebration,decerebration,high urinaryhigh urinary
catecholamines,catecholamines,death in infancydeath in infancy
IXIX Liver phosphorylaseLiver phosphorylasekinasekinase
Hepatomegaly,Hepatomegaly,occasional fastingoccasional fasting
hypoglycemiahypoglycemia
XX Liver and muscle cAMPLiver and muscle cAMP--
dependent kinasedependent kinase
HepatomegalyHepatomegaly
onlyonly
8/9/2019 ENZYMOLOGY (3)
32/35
LIPIDOSESLIPIDOSES
a group of inherited disordersa group of inherited disorderscharacterized by thecharacterized by the
accumulation of lipids inaccumulation of lipids intissuestissues especially the brainespecially the brain
due todue to
deficiency in a particulardeficiency in a particularsphingolipid catabolic enzymesphingolipid catabolic enzyme
8/9/2019 ENZYMOLOGY (3)
33/35
NiemannNiemann--Pick diseasePick disease Deficiency inDeficiency in sphingomyelinasesphingomyelinase andand
accumulation of sphingomyelinaccumulation of sphingomyelin
Gauchers diseaseGauchers disease
Deficiency inDeficiency in FF--DD--glucosidaseglucosidase andand
accumulation of glucocerebrosideaccumulation of glucocerebroside
8/9/2019 ENZYMOLOGY (3)
34/35
Krabbes diseaseKrabbes disease Deficiency inDeficiency in FF--DD--galactosidasegalactosidase andand
accumulation ofaccumulation of galactocerebsidesgalactocerebsides
Fabrys diseaseFabrys disease
Deficiency inDeficiency in EE--DD--galactosidasegalactosidase andand
accumulation of ceramide trihexosideaccumulation of ceramide trihexoside
8/9/2019 ENZYMOLOGY (3)
35/35
TayTay--Sachs diseaseSachs disease Deficiency inDeficiency in FF--DD--hexaminidase Ahexaminidase A
andand accumulation of ganglioside GMaccumulation of ganglioside GM22
Metachromatic LeukodystrophyMetachromatic Leukodystrophy
Deficiency inDeficiency in sulfatide sulfatasesulfatide sulfatase andandaccumulation ofaccumulation of FF--sulfogalactocerebrosidesulfogalactocerebroside